Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL.-MedSci.cn

Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL.

Abramson, JS; Gordon, LI; Palomba, ML; Lunning, MA; Arnason, JE; Forero-Torres, A; Wang, M; Maloney, DG; Sehgal, A; Andreadis, C; Purev, E; Solomon, SR; Ghosh, N; Albertson, TM; Xie, BH; Garcia, J; Siddiqi, T

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):

科室
- - 订阅+
  - 更多科室
工具
服务